Impact of mass screening for gluten-sensitive enteropathy in working population

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

320

HTML

3273

Figures (1-4)

210

Tables (1-5)

211

Sum=4014

Mar 21, 2009 (publication date) through Nov 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Mar 21, 2009; 15(11): 1331-1338
Published online Mar 21, 2009. doi: 10.3748/wjg.15.1331

Table 4 Evolution of symptoms after 1 year of follow-up for those patients who adhered to a GFD (n = 10; 5 Marsh I, 5 Marsh III)

	Basal (mean values of VAS)	After 1 year of GFD (mean values of VAS)	Pvalue
Flatulence	28 ± 8.9	5 ± 3.4	0.028
Distension	42 ± 10.9	7 ± 4.7	0.014
Abdominal pain	28 ± 9.0	7 ± 5.1	0.007
Diarrhea	24 ± 10.2	4 ± 2.6	0.063
Asthenia	28 ± 12.3	12 ± 6.6	0.133

Citation: Mariné M, Fernández-Bañares F, Alsina M, Farré C, Cortijo M, Santaolalla R, Salas A, Tomàs M, Abugattas E, Loras C, Ordás I, Viver JM, Esteve M. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009; 15(11): 1331-1338
URL: https://www.wjgnet.com/1007-9327/full/v15/i11/1331.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1331